Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06696339 · ClinicalTrials.gov registry record
Assessment of Heart Rate Measurement Accuracy for the PreemptiveAI SDK in Adults
A clinical trial of Heart Rate in the General Public, sponsored by PreemptiveAI.
- Active
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT06696339 is a study of Heart Rate in the General Public that is active but no longer recruiting, run by PreemptiveAI. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06696339, a study of Heart Rate in the General Public, is active but no longer recruiting, sponsored by PreemptiveAI.
- ACTIVE NOT RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to assess the accuracy of the PreemptiveAI SDK to measure heart rate for adults as compared to an FDA-approved ground truth device. Participants will: * Complete a demographics and health history survey * Apply and wear ground truth equipment such as a pulse oximeter and ECG * Measure their heart rate 8 times with 4 different smartphones using the PreemptiveAI SDK
Conditions Studied
Interventions
- DEVICE PreemptiveAI SDK
Study Locations (1)
Washington
- Paul Allen Institute for Artificial Intelligence - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-10-03 |
| Est. Completion | 2025-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06696339
The ClinicalTrials.gov registry entry for NCT06696339 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PreemptiveAI, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Rate in the General Public appearing as the primary indexed condition, and to 1 intervention - of which PreemptiveAI SDK is the first listed.
NCT06696339 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT06696339 about?
NCT06696339 is a clinical study titled "Assessment of Heart Rate Measurement Accuracy for the PreemptiveAI SDK in Adults". The goal of this clinical trial is to assess the accuracy of the PreemptiveAI SDK to measure heart rate for adults as compared to an FDA-approved ground truth device. Participants will: * Complete a demographics and health history survey * Apply and wear ground truth equipment such as a pulse oxim...
What is the current status of trial NCT06696339?
This trial is currently active not recruiting. The enrollment target is 100 participants. The study started on 2024-10-03. Estimated completion is 2025-03-01.
What conditions does trial NCT06696339 study?
This clinical trial studies the following conditions: Heart Rate in the General Public.
What interventions are being tested in trial NCT06696339?
The interventions under investigation include: PreemptiveAI SDK (DEVICE).
Who is sponsoring clinical trial NCT06696339?
This trial is sponsored by PreemptiveAI, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06696339 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.